Financials
- Market Capitalization 2.1 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.87
ratio cours/chiffre d'affaires
7 992.14
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1895 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.07 USD | +2.20% | +0.26% | -11.18% | -15.06% | 2.16 B USD | ||
| 1897 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.44 USD | -1.29% | +5.76% | +3.30% | +16.74% | 2.16 B USD | ||
| 1919 | NVAX Novavax, Inc. - Common Stock | 12.72 USD | -0.24% | +21.37% | +35.03% | +51.07% | 2.10 B USD | ||
| 1932 | PHVS Pharvaris N.V. - Ordinary Shares | 31.63 USD | +1.70% | +3.10% | -17.31% | +42.09% | 2.06 B USD |